Cavinton is a well-known drug that has been used in medicine for several decades and is considered one of the most vital medicines. Numerous studies and experience of application show effective results in the treatment of a number of pathologies, prevention of severe consequences and complications.
Composition, form and effect of Cavinton
Cavinton has two forms of release:
- pills;
- concentrate for solution preparation.
There is also the tabletted form of Cavinton forte, which contains a large concentration of active substance.
The active ingredient is vinpocetine, a semi-synthetic substance, which is obtained from the alkaloid vinokamine contained in the plant of periwinkles small.
The drug has the following pharmacological action:
- improves blood flow and microcirculation in the brain;
- improves the transport of oxygen to tissues;
- promotes vasodilation;
- increases the stability of nerve cells to the effect of various adverse factors;
- reduces the ability of platelets and other blood components to aggregate, reduces blood viscosity and reduces the risk of thrombus formation;
- improves the tolerance of cerebral oxygen deficiency (by activating glucose utilization, as well as metabolic processes with adrenaline and serotonin in brain tissues);
- normalizes the supply of bleeding areas of the brain (through the relaxation of the smooth muscles of cerebral vessels);
- contributes to a non-intensive lowering of systemic blood pressure.
It should be noted that this drug acts selectively, affecting the affected areas and not affecting the body as a whole.
Indications for Cavinton
Indications for the use of injections and droppers with Cavinton (intravenously, drip), as well as indications for the use of Cavinton in the form of tablets (including forte), are common. The choice of the form of the drug, its dosage and the frequency of reception is individually determined depending on the type of illness, the severity and severity of the process, the age of the patient, etc. So, the medicine is recommended for the following diagnoses:
1. Insufficiency of cerebral circulation in acute or chronic stage, including:
- progressive stroke;
- hypertension;
- transistor ischemic attacks;
- post-stroke state;
- atherosclerotic lesion of cerebral vessels;
- organic brain damage of hypertensive or post-traumatic origin;
- vertebrobasilar insufficiency;
- cardiovascular dementia.
2. Mental and neurological disorders in patients with cerebrovascular insufficiency, including:
- memory impairment ;
- dizziness;
- headache;
- speech and motor disorders.
3. Vascular ophthalmic diseases:
- angiospasm of the choroid and retina;
- lesions of the choroid, retina or yellow spot;
- secondary glaucoma;
- thrombosis or occlusion of central retinal vessels, etc.
4. Lesions of ENT organs:
- Meniere's disease ;
- idiopathic noises in the ears;
- hypoacusis of toxic origin;
- neuritis of the auditory nerve;
- dizziness of labyrinth origin, etc.
5. Climacteric syndrome with vasovegetative symptoms.
Contraindications to the use of Cavinton:
- hemorrhagic stroke in acute form;
- severe stage of ischemic heart disease;
- arrhythmias with severe course;
- pregnancy;
- the period of breastfeeding;
- hypersensitivity to the components of the drug.